Upper Arlington, OH, United States of America

Abhay Satoskar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abhay Satoskar. Retrieved from https://idiyas.com/inventor/abhay-satoskar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abhay Satoskar and His Work on Leishmania Vaccines.

Introduction

Abhay Satoskar is an inventor associated with Upper Arlington, Ohio. His patent work includes research into live attenuated vaccines designed to protect against leishmaniasis while improving safety.

Latest Patents

Satoskar is listed as an inventor on 1 patent: “Live Attenuated Leishmania Parasite Vaccines with Enhanced Safety Characteristics.” The invention concerns attenuated Leishmania parasites developed as vaccine candidates with enhanced safety characteristics.

Career Highlights

The patent is assigned to the United States of America, as represented by the Secretary of the Department of Health and Human Services. It reflects work at the intersection of infectious-disease research and vaccine development.

Collaborations

Satoskar’s listed coworkers include Hira L. Nakhasi and Ranadhir Dey, who are also associated with the patent.

Conclusion

Abhay Satoskar’s patent contribution focuses on developing safer live attenuated Leishmania vaccine candidates, highlighting the role of collaborative research in advancing infectious-disease prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…